| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.4 | 0.2 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |